CRISPR Collaboration Agreement - Additional Information (Details) - Research Collaboration Agreement |
6 Months Ended | |
|---|---|---|
|
May 05, 2021
CrisprCas9
|
Jun. 30, 2026
USD ($)
|
|
| Development and Regulatory Approval Milestones | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Potential future payments | totaling less than mid-twenty million dollars | |
| Amount paid under the agreement | $ 0 | |
| Amounts owed under the agreement | $ 0 | |
| NK Cell Products | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Number of non-exclusive rights to gene editing targets | CrisprCas9 | 5 | |
| Specified TA | Development and Regulatory Approval Milestones | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Potential future payments | totaling less than high-forty million dollars |